Humacyte, Inc. (HUMA) Tops Q4 EPS by 9c

Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Ericsson (ERIC) Tops Q2 EPS by 3c
• Morgan Stanley Downgrades Tryg A/S (TRYG:DC) (TGVSF) to Underweight
• Jefferies Upgrades Salzgitter AG (SZG:GR) (SZGPY) to Buy